DALLAS, April 8, 2010 (GLOBE NEWSWIRE) -- BeaconEquity.com announces an investment report featuring PURE Bioscience (Nasdaq:PURE). The report includes financial, comparative and investment analyses, and pertinent industry information you need to know to make an educated investment decision.
The full report is available at: http://www.beaconequity.com/i/PURE
Get our alerts BEFORE the rest of the market. Follow us on Twitter: http://twitter.com/BeaconEquity
PURE Bioscience (PURE) is engaged in the development and commercialization of bioscience technologies. The Company is engaged in developing technology-based bioscience products, including its silver dihydrogen citrate (SDC)-based antimicrobials. SDC is an electrolytically generated source of stabilized ionic silver that can serve as the basis for a range of products in diverse markets. SDC liquid is colorless, odorless, tasteless, non-caustic and formulates well with other compounds.
Message Board Search for PURE: http://www.boardcentral.com/boards/PURE
In the report, the analyst notes:
"PURE recently reported product revenues for the fiscal second quarter ended January 31, 2010, of $327,000, up from product revenues of $34,800 in the same quarter of the prior fiscal year. The Company reported a net loss of $1,766,200 or $(0.05) per share for the current quarter, improved from a net loss of $2,219,800 or $(0.07) per share in the second fiscal quarter last year.
"PURE recently announced that it has received U.S. Environmental Protection Agency (EPA) registration for its SDC-based disinfectant and food contact surface sanitizer. The product will be marketed as IV-7 Ultimate Germ Defense for Food Contact Surfaces™ (IV-7) by PURE's sales and marketing representative, Richmont Sciences LLC. An EPA Category IV disinfectant/sanitizer, IV-7 provides an advantageous combination of high efficacy, low toxicity and efficiency by rapidly eliminating dangerous pathogens, yet no rinse is required."
To read the entire report visit: http://www.beaconequity.com/i/PURE
See what investors are saying about PURE at penny stock forum
BeaconEquity.com is one of the industry's largest small-cap report providers. Beacon strives to provide a balanced view of many promising small-cap companies that would otherwise fall under the radar of the typical Wall Street investor. We provide investors with an excellent first step in their research and due diligence by providing daily trading ideas, and consolidating the public information available on them. For more information on Beacon Research, please visit http://www.BeaconEquity.com.
Beacon Equity Disclosure
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the "SEC") or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. Beacon Equity Research nor its affiliates have a beneficial interest in the mentioned company; nor have they received compensation of any kind for any of the companies listed in this communication. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.